Search Results 1011-1020 of 16075 for pharmacogenetics
The purpose of this study is to determine if a blood test called "pancreatic polypeptide" can help distinguish between patients with diabetes mellitus with and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. To describe the clinical, laboratory, pathologic, imaging findings, therapy and outcomes in all patients with Fibromuscular Dysplasia ...
This research takes a dual perspective (patients and physicians) to examine social media use by chronic disease patients who share their narratives of illness ...
Doctors and scientists in the Hematologic Malignancies Program of the Mayo Clinic Comprehensive Cancer Center are working on improving the diagnosis and ...
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or without ...
D., has been mainly focused on autonomic disorders, specifically pure autonomic failure, autoimmune autonomic neuropathies, postural tachycardia syndrome and ...
Faculty members in the Department of Biochemistry and Molecular Biology developing new genetic, proteomic and biomathematics methods to drive research in ...
mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both arms will continue treatment until ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.